The global optical genome mapping market size was estimated to be USD 0.116 billion in 2023 and is expected to reach at USD 1.93 billion by 2034 with a CAGR of 29.13% during the forecast period 2024-2034. Surge in government initiatives to expand research efforts in the field of genome mapping, rising focus on the development of precision healthcare & diagnostics for major diseases, increasing mergers & acquisitions within market players, growing demand for advanced genomic analysis tools & techniques, surge in technological advancements in optical mapping technologies, rising research & development activities, and increasing introduction of advanced optical genome mapping products are some of the key factors boosting the market growth.
Increasing introduction of advanced optical genome mapping products is predicted to boost the market growth during the forecast period. Ongoing advancements in optical mapping technologies have been instrumental in driving the growth of the market. Innovations in high-resolution imaging, DNA labeling, and data analysis algorithms have enhanced the precision and efficiency of optical genome mapping, rendering it a compelling option for various applications, such as genome assembly, structural variant detection, and genotyping. For instance, in June 2022, Bionano Genomics, Inc. and Hamilton have collaborated to develop the Long String VANTAGE, a technology designed for the isolation of Ultra High Molecular Weight (UHMW) DNA for optical genome mapping (OGM).
By product, services was the highest revenue-grossing segment in the global optical genome mapping market in 2023 owing to the surge in number of outsourced service vendors, ongoing innovation, diverse applications, & its integral role in advancing genomics research and its practical applications, growing demand for OGM services for genomics research & clinical applications, and increasing collaborations within market players. For instance, in November 2022, Bionano Genomics has acquired Purigen Biosystems, Inc. to enhance DNA separation capabilities for optical genome mapping (OGM) and to identify challenging sample types in novel applications using Isotachophoresis (ITP) on the ionic purification system. Additionally, consumables & reagents is predicted to grow at fastest CAGR during the forecast period owing to the increasing demand for DNA extraction kits, buffer solutions, labelling kits, microfluidic chips or flow cells, & others are crucial for preparing, processing, and analysing genomic samples using OGM technology, surge in adoption in genomics research & clinical applications, growing demand for the crucial materials & chemicals employed in the genome mapping process.
By application, structural variant detection was the highest revenue-grossing segment in the global optical genome mapping market in 2023 owing to the high-resolution imaging capabilities of optical genome mapping & its capacity to analyze individual DNA molecules render it exceptionally suitable for identifying structural variants, increasing research efforts focused on large-scale genome identification, and rising launch of new products. For instance, in February 2022, Arima Genomics has introduced two new product offerings, namely the Arima-HiC+ FFPE kit. This tool enables scientists to identify and explore structural variants in their 3D genomic data. By integrating structural variant detection with 3D genome orientation data, researchers can gain deeper insights into how these variants impact gene and cellular function. Ultimately, these discoveries will assist scientists in uncovering novel disease mechanisms and therapeutic targets. Additionally, genome assembly is predicted to grow at fastest CAGR during the forecast period owing to its capacity to offer high-resolution & long-range structural insights into DNA molecules, increasing research & development activities, and growing focus on the development of technologically advanced products.
By end-user, academic research institutes was the highest revenue-grossing segment in the global optical genome mapping market in 2023 owing to the surge in adoption of OGM technologies to advance their genomics research efforts, rising demand for advanced tools & techniques by researchers that can provide a more comprehensive understanding of genomes. Additionally, hospitals & clinical laboratories is predicted to grow at fastest CAGR during the forecast period owing to the rising collaboration within instrument manufacturers & hospitals. For instance, in March 2023, Bionano has disclosed its participation in the annual meeting of the American College of Medical Genetics and Genomics, where it will demonstrate the applications of Optical Genome Mapping (OGM) in the context of rare genetic disorders and constitutional disorders.
North America region is anticipated for the highest revenue share during the forecast period owing to the rising development in the field of genetic research, the presence of leading manufacturers, surge in clinical trial procedures, and increasing launch of advanced test products. For instance, in March 2023, Bionano Genomics has introduced two new clinical tests based on Optical Genome Mapping (OGM), namely OGM-Dx prenatal whole genome structural variant and OGM-Dx postnatal whole genome structural variant. These tests offer a comprehensive assessment of structural variants across the entire genome and screen for common and rare chromosomal abnormalities. They aim to assist clinicians in diagnosing and managing their patients' medical conditions. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the growing research & development activities, growing technological developments, surge in demand for precise and reliable genomic analysis tools, and increasing adoption of optical genome mapping in research institutions & pharmaceutical companies. For instance, in July 2023, The Centre for Cellular & Molecular Biology (CCMB) in Hyderabad, India, has introduced a state-of-the-art high-end next-generation genetic testing tool known as 'Optical Genome Mapping' (OGM). This tool has the potential to uncover genomic anomalies responsible for various hereditary diseases in humans.
Increasing introduction of advanced optical genome mapping products is predicted to boost the market growth during the forecast period. Ongoing advancements in optical mapping technologies have been instrumental in driving the growth of the market. Innovations in high-resolution imaging, DNA labeling, and data analysis algorithms have enhanced the precision and efficiency of optical genome mapping, rendering it a compelling option for various applications, such as genome assembly, structural variant detection, and genotyping. For instance, in June 2022, Bionano Genomics, Inc. and Hamilton have collaborated to develop the Long String VANTAGE, a technology designed for the isolation of Ultra High Molecular Weight (UHMW) DNA for optical genome mapping (OGM).
By product, services was the highest revenue-grossing segment in the global optical genome mapping market in 2023 owing to the surge in number of outsourced service vendors, ongoing innovation, diverse applications, & its integral role in advancing genomics research and its practical applications, growing demand for OGM services for genomics research & clinical applications, and increasing collaborations within market players. For instance, in November 2022, Bionano Genomics has acquired Purigen Biosystems, Inc. to enhance DNA separation capabilities for optical genome mapping (OGM) and to identify challenging sample types in novel applications using Isotachophoresis (ITP) on the ionic purification system. Additionally, consumables & reagents is predicted to grow at fastest CAGR during the forecast period owing to the increasing demand for DNA extraction kits, buffer solutions, labelling kits, microfluidic chips or flow cells, & others are crucial for preparing, processing, and analysing genomic samples using OGM technology, surge in adoption in genomics research & clinical applications, growing demand for the crucial materials & chemicals employed in the genome mapping process.
By application, structural variant detection was the highest revenue-grossing segment in the global optical genome mapping market in 2023 owing to the high-resolution imaging capabilities of optical genome mapping & its capacity to analyze individual DNA molecules render it exceptionally suitable for identifying structural variants, increasing research efforts focused on large-scale genome identification, and rising launch of new products. For instance, in February 2022, Arima Genomics has introduced two new product offerings, namely the Arima-HiC+ FFPE kit. This tool enables scientists to identify and explore structural variants in their 3D genomic data. By integrating structural variant detection with 3D genome orientation data, researchers can gain deeper insights into how these variants impact gene and cellular function. Ultimately, these discoveries will assist scientists in uncovering novel disease mechanisms and therapeutic targets. Additionally, genome assembly is predicted to grow at fastest CAGR during the forecast period owing to its capacity to offer high-resolution & long-range structural insights into DNA molecules, increasing research & development activities, and growing focus on the development of technologically advanced products.
By end-user, academic research institutes was the highest revenue-grossing segment in the global optical genome mapping market in 2023 owing to the surge in adoption of OGM technologies to advance their genomics research efforts, rising demand for advanced tools & techniques by researchers that can provide a more comprehensive understanding of genomes. Additionally, hospitals & clinical laboratories is predicted to grow at fastest CAGR during the forecast period owing to the rising collaboration within instrument manufacturers & hospitals. For instance, in March 2023, Bionano has disclosed its participation in the annual meeting of the American College of Medical Genetics and Genomics, where it will demonstrate the applications of Optical Genome Mapping (OGM) in the context of rare genetic disorders and constitutional disorders.
North America region is anticipated for the highest revenue share during the forecast period owing to the rising development in the field of genetic research, the presence of leading manufacturers, surge in clinical trial procedures, and increasing launch of advanced test products. For instance, in March 2023, Bionano Genomics has introduced two new clinical tests based on Optical Genome Mapping (OGM), namely OGM-Dx prenatal whole genome structural variant and OGM-Dx postnatal whole genome structural variant. These tests offer a comprehensive assessment of structural variants across the entire genome and screen for common and rare chromosomal abnormalities. They aim to assist clinicians in diagnosing and managing their patients' medical conditions. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the growing research & development activities, growing technological developments, surge in demand for precise and reliable genomic analysis tools, and increasing adoption of optical genome mapping in research institutions & pharmaceutical companies. For instance, in July 2023, The Centre for Cellular & Molecular Biology (CCMB) in Hyderabad, India, has introduced a state-of-the-art high-end next-generation genetic testing tool known as 'Optical Genome Mapping' (OGM). This tool has the potential to uncover genomic anomalies responsible for various hereditary diseases in humans.
Segmentation: Optical Genome Mapping Market Report 2023 - 2034
Optical Genome Mapping Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Consumables & Reagents
- Services
- Instruments
- Software
Optical Genome Mapping Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Genome Assembly
- Microbial Strain Typing
- Structural Variant Detection
- Others
Optical Genome Mapping Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Research & Academic Institutions
- Hospitals & Clinical Laboratories
- Biotechnology & Pharmaceutical Companies
- Others
Optical Genome Mapping Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Optical Genome Mapping Market: Product Estimates & Trend Analysis
8. Optical Genome Mapping Market: Application Estimates & Trend Analysis
9. Optical Genome Mapping Market: End-user Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Optical Genome Mapping Market
12. Europe Global Optical Genome Mapping Market
13. Asia Pacific Global Optical Genome Mapping Market
14. Latin America Global Optical Genome Mapping Market
15. MEA Global Optical Genome Mapping Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Bionano Genomics
- SourceBio International Limited (Source BioScience)
- MedGenome
- Cerba
- Nucleome Informatics Private Limited
- Genohub Inc.
- Praxis Genomics Llc
- Hofkens Lab
- PerkinElmer (PerkinElmer Genomics)
- INRAE (French Plant Genomic Resources Center (CNRGV))
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | January 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 0.12 Billion |
| Forecasted Market Value ( USD | $ 1.93 Billion |
| Compound Annual Growth Rate | 29.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
